Picture of OptiBiotix Health logo

OPTI OptiBiotix Health News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

REG - SkinBioTherapeutics OptiBiotix Health - Holding(s) in Company

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230130:nRSd3057Oa&default-theme=true

RNS Number : 3057O  SkinBioTherapeutics PLC  30 January 2023

TR-1: Standard form for notification of major holdings

 

 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the
 FCA in Microsoft Word format if possible)i

 1a. Identity of the issuer or the underlying issuer of existing shares to
 which voting rights are

attachedii:                                                                                                                              SKINBIOTHERAPEUTICS PLC
 1b. Please indicate if the issuer is a non-UK issuer(please mark with an "X"
 if appropriate)
 Non-UK issuer
 2. Reason for the notification(please mark the appropriate box or boxes with
 an "X")
 An acquisition or disposal of voting rights
 An acquisition or disposal of financial instruments
 An event changing the breakdown of voting rights                                                                                                                                                                                x
 Other (please specify)iii:
 3. Details of person subject to the notification obligationiv
 Name                                                                                                                                      Optibiotix Health Plc
 City and country of registered office (if applicable)                                                                                     UK
 4. Full name of shareholder(s)(if different from 3.)v
 Name
 City and country of registered office (if applicable)
 5. Date on which the threshold was crossed or reachedvi:                                                                                  05/01/2023
 6. Date on which issuer notified (DD/MM/YYYY):                                                                                            30/01/2023
 7. Total positions of person(s) subject to the notification obligation
                                                    % of voting rights at- tached to shares (to- tal of 8. A)  % of voting rights through financial instru- ments                                       Total number of voting rights of is- suervii

                                                                                                               (total of 8.B 1 + 8.B 2)                                Total of both in % (8.A + 8.B)
 Resulting situation on the date on which

 threshold was crossed or reached                   18.71%                                                                                                                                              173,138,854
 Position of previous notification (if applicable)

                                                    20.67%

 

1

 8. Notified details of the resulting situation on the date on which the
 threshold was crossed or reachedviii
 A: Voting rights attached to shares
 Class/type of shares                            Number of voting rightsix                                                                                   % of voting rights

 ISIN code (if possible)
                                                 Direct                                          Indirect                                                    Direct                                           Indirect

                                                 (Art 9 of Directive 2004/109/EC) (DTR5.1)       (Art 10 of Directive 2004/109/EC) (DTR5.2.1)                (Art 9 of Directive 2004/109/EC) (DTR5.1)        (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
                                                 32,402,206                                                                                                  18.71%

 SUBTOTAL 8. A                                   32,402,206                                                                                                  18.71%

 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
 (DTR5.3.1.1 (a))
                                                                                                                                     Number of voting rights that may be acquired if the instrument is

 Type of financial in- strument                  Expiration datex        Exercise/ Conversion Periodxi                               exercised/converted.                                                     % of voting rights

                                                                         SUBTOTAL 8. B 1

 B 2: Financial Instruments with similar economic effect according to Art.
 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
 Type of financial instrument  Expiration datex                          Exercise/ Conversion Pe-                  Physical or cash                                                  Number of voting rights

                                                                         riod xi                                   settlementxii                                                                              % of voting rights

                                                                                                                   SUBTOTAL

                                                                                                                   8.B.2

 

 9. Information in relation to the person subject to the notification
 obligation (please mark the applicable box with an "X")
 Person subject to the notification obligation is not controlled by any natural                                                                                                                                             X
 person or legal entity and does not control any other undertaking(s) holding
 directly or indirectly an interest in the (underlying) issuerxiii
 Full chain of controlled undertakings through which the voting rights and/or
 the

 financial instruments are effectively held starting with the ultimate
 controlling natural person or legal entityxiv

 (please add additional rows as necessary)
                             % of voting rights if it equals or is higher than the notifiable threshold  % of voting rights through financial in- struments if it equals or is higher  Total of both if it equals or is higher than the notifiable threshold

                                                                                                       than the

                                                                                                       notifiable threshold
 Namexv

 10. In case of proxy voting, please identify:
 Name of the proxy holder
 The number and % of voting rights held
 The date until which the voting rights will be held

 11. Additional informationxvi

 

 Place of completion  London
 Date of completion   30/01/2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  HOLBMMFTMTTJBAJ

Recent news on OptiBiotix Health

See all news